about
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activityDifferential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypesHIV-1 Vif, APOBEC, and intrinsic immunityHuman cytidine deaminase APOBEC3H restricts HIV-1 replicationAll APOBEC3 family proteins differentially inhibit LINE-1 retrotranspositionHost restriction factors for hepatitis C virusMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allReversed functional organization of mouse and human APOBEC3 cytidine deaminase domainsNewly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase HMouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1)APOBEC3G: an intracellular centurionThe restriction of zoonotic PERV transmission by human APOBEC3G.APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.Are viruses inhibited by APOBEC3 molecules from their host species?C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism.APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa.Biophysical characterization of DNA binding from single molecule force measurementsTwo genetic determinants acquired late in Mus evolution regulate the inclusion of exon 5, which alters mouse APOBEC3 translation efficiencyStably expressed APOBEC3F has negligible antiviral activity.HIV restriction by APOBEC3 in humanized mice.Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B.ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsidCytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.Retroelements versus APOBEC3 family members: No great escape from the magnificent sevenThe preferred nucleotide contexts of the AID/APOBEC cytidine deaminases have differential effects when mutating retrotransposon and virus sequences compared to host genesAPOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle.Host restriction factors in retroviral infection: promises in virus-host interaction.APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic miceHuman immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1.NF-IL6 (C/EBPbeta) induces HIV-1 replication by inhibiting cytidine deaminase APOBEC3G.Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells.Current topics in prevention of human T-cell leukemia virus type i infection: NF-kappa B inhibitors and APOBEC3.Human cellular restriction factors that target HIV-1 replication.
P2860
Q24310242-854825E2-DAAB-4EC9-9B86-E64E015594FAQ24311896-6A5AB8D6-31A1-4E3A-9C3F-B22A1ECB2107Q24565021-061A0C85-CF66-4BC4-840D-684DF24D867BQ24612992-E19E339F-A663-4921-8A33-56DC9F4C749FQ24647833-22AC9FE9-CF45-4975-A7E3-EBC35C59C3C5Q24653682-0F3E31BD-A800-40F4-86C6-C03D2D8391D0Q24675735-3A54D014-AD81-465A-8C1F-65252116BD11Q26773258-109C312F-9AA4-4CDC-B99D-507C3B9FCD51Q26823568-CB6A71FD-3BCC-44FE-AE2F-A30E4A9DF26FQ28266980-97A75C5E-F6C7-4AE5-99BE-F729F604F49CQ28469134-4A43F05F-40CD-4AFD-85B3-1AFEDDEBD370Q28510924-60F368D2-2A50-45D8-A5FC-6970FFAE15FDQ28754989-CEB8654A-B498-4D13-B3E0-31B750446DF7Q33298609-7C782137-A7A2-4EC4-9891-5E9C12034FDEQ33349452-F73D03BB-9747-4BB5-A2AB-77D31C27D348Q33434458-ED07FBD8-C653-4105-8E0E-B884FA133E66Q33581258-8D2FBAB1-9E3A-4462-BB46-F55AEBD170BFQ33826968-08A6D566-7C09-45C1-9568-436F9FD807F5Q34064195-76B71675-EF95-40C7-A4F1-9BAA44429BB6Q34091700-904AF0EC-D309-4EAC-8284-9D4A248E1118Q34139947-82AEAB31-2C99-4C9C-B17A-EAD8EF82BE98Q34190587-AA6059D4-D25B-48C4-AC84-EC98E0FF25F5Q34649651-DA2E478C-3732-4556-BAA6-77540A945368Q35068754-8EA9A9FF-165D-49C1-B580-0B5F436E188EQ35192821-3EB07186-1E46-4D3C-B341-D3091B24E563Q35579416-FA9EDEF7-A479-4961-AA2B-BA8850394CD4Q35669808-EF4957C8-750E-4AED-8D88-6426ACAD3853Q35914312-11248575-8F10-47D8-8C96-E796C92DA6DAQ36162443-F51000A0-6B7C-4603-A69E-686C0D77D524Q36330081-2464ABFE-E86F-41E4-95A8-3FF2618C1E1BQ36366147-86A9A983-B88F-45EA-A154-16F8C7C605BDQ36548179-1A839E78-6A8D-4219-AA2F-E7343DAA1B8AQ36747910-432B5BBA-8D0E-490E-92C3-547EB8CDB341Q36933894-07C7ED9F-6BE2-4BF7-8AFD-A43D0A52D362Q36937148-816CA653-4CAE-46A6-BB41-AF2A77A37EAAQ37091342-ED21F554-A03E-478F-9485-FC6636D294FAQ37099784-2D18CF03-91BD-4B19-888A-415642C3FDD2Q37186249-4C12BD21-FE0E-4E0A-98D9-C46F06B3B5D2Q37198681-7103FE32-EB98-4172-B616-4A11D8A7F9E1Q37382519-35EB0C4B-ED7A-475E-A072-E83602CE3E2A
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
APOBEC3G targets human T-cell leukemia virus type 1
@nl
APOBEC3G targets human T-cell leukemia virus type 1.
@ast
APOBEC3G targets human T-cell leukemia virus type 1.
@en
type
label
APOBEC3G targets human T-cell leukemia virus type 1
@nl
APOBEC3G targets human T-cell leukemia virus type 1.
@ast
APOBEC3G targets human T-cell leukemia virus type 1.
@en
prefLabel
APOBEC3G targets human T-cell leukemia virus type 1
@nl
APOBEC3G targets human T-cell leukemia virus type 1.
@ast
APOBEC3G targets human T-cell leukemia virus type 1.
@en
P2093
P2860
P356
P1433
P1476
APOBEC3G targets human T-cell leukemia virus type 1
@en
P2093
Aierkin Abudu
Akifumi Takaori-Kondo
Amane Sasada
Kotaro Shirakawa
Masakatsu Hishizawa
Masayuki Kobayashi
Takashi Uchiyama
Yuetsu Tanaka
P2860
P2888
P356
10.1186/1742-4690-2-32
P407
P50
P577
2005-05-19T00:00:00Z
P5875
P6179
1001638527